DE873543C
(de)
|
1942-10-28 |
1953-04-16 |
Basf Ag |
Verfahren zur Herstellung von hydroxyl- bzw. sulfhydryl-gruppenhaltigen Dicarbaminsaeureestern
|
US3687808A
(en)
|
1969-08-14 |
1972-08-29 |
Univ Leland Stanford Junior |
Synthetic polynucleotides
|
US4550163A
(en)
|
1979-02-05 |
1985-10-29 |
Abbott Laboratories |
Ligand analog-irreversible enzyme inhibitor conjugates
|
US20030232355A1
(en)
|
1992-05-22 |
2003-12-18 |
Isis Pharmaceuticals, Inc. |
Double-stranded peptide nucleic acids
|
US5631148A
(en)
|
1994-04-22 |
1997-05-20 |
Chiron Corporation |
Ribozymes with product ejection by strand displacement
|
GB9621367D0
(en)
|
1996-10-14 |
1996-12-04 |
Isis Innovation |
Chiral peptide nucleic acids
|
US6197557B1
(en)
|
1997-03-05 |
2001-03-06 |
The Regents Of The University Of Michigan |
Compositions and methods for analysis of nucleic acids
|
EP1013770A1
(en)
|
1998-12-23 |
2000-06-28 |
Université Louis Pasteur de Strasbourg |
Non-viral transfection vector
|
FR2790757B1
(fr)
|
1999-03-09 |
2003-08-01 |
Bioalliance Pharma |
Oligonucleotides contenant une sequence antisens stabilises par une structure secondaire et compositions pharmaceutiques les contenant.
|
US6852334B1
(en)
|
1999-04-20 |
2005-02-08 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
US7833992B2
(en)
|
2001-05-18 |
2010-11-16 |
Merck Sharpe & Dohme |
Conjugates and compositions for cellular delivery
|
US6962906B2
(en)
|
2000-03-14 |
2005-11-08 |
Active Motif |
Oligonucleotide analogues, methods of synthesis and methods of use
|
US7256275B2
(en)
|
2001-03-09 |
2007-08-14 |
Boston Probes, Inc. |
Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation
|
EP1627061B1
(en)
|
2001-05-18 |
2009-08-12 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
CA2465129A1
(en)
|
2001-10-29 |
2003-05-08 |
Mcgill University |
Acyclic linker-containing oligonucleotides and uses thereof
|
AU2003219900A1
(en)
|
2002-02-22 |
2003-09-09 |
James R. Eshleman |
Antigene locks and therapeutic uses thereof
|
AU2003224725A1
(en)
|
2002-03-20 |
2003-10-08 |
Brigham And Women's Hospital, Inc. |
Hiv therapeutic
|
EP2258847B2
(en)
|
2002-08-05 |
2020-07-01 |
Silence Therapeutics GmbH |
Futher novel forms of interfering RNA molecules
|
US20040058886A1
(en)
|
2002-08-08 |
2004-03-25 |
Dharmacon, Inc. |
Short interfering RNAs having a hairpin structure containing a non-nucleotide loop
|
US6936651B2
(en)
|
2002-12-17 |
2005-08-30 |
E. I. Du Pont De Nemours And Company |
Compatibility improvement in crystalline thermoplastics with mineral fillers
|
WO2004090108A2
(en)
|
2003-04-03 |
2004-10-21 |
Alnylam Pharmaceuticals |
Irna conjugates
|
CA2528958A1
(en)
|
2003-06-12 |
2004-12-23 |
Applera Corporation |
Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same
|
US8106180B2
(en)
|
2003-08-07 |
2012-01-31 |
Whitehead Institute For Biomedical Research |
Methods and products for expression of micro RNAs
|
CN1860228B
(zh)
|
2003-09-30 |
2010-04-28 |
安琪士摩奇株式会社 |
订书钉型寡核苷酸及包含该订书钉型寡核苷酸的药物
|
JP2007508030A
(ja)
|
2003-10-14 |
2007-04-05 |
カーネル・バイオファーマ・インコーポレイテッド |
血液脳関門を介してpnaを送達するための2相pna結合体
|
US20050209141A1
(en)
|
2003-10-17 |
2005-09-22 |
Silver Randi B |
Mast cell-derived renin
|
US7615618B2
(en)
|
2004-06-30 |
2009-11-10 |
Alnylam Pharmaceuticals, Inc. |
Oligonucleotides comprising a non-phosphate backbone linkage
|
PL1781787T3
(pl)
|
2004-08-23 |
2018-01-31 |
Sylentis Sau |
Leczenie zaburzeń oka charakteryzowanych przez podwyższone ciśnienie wewnątrzgałkowe przy użyciu siRNA
|
WO2006022325A1
(ja)
|
2004-08-26 |
2006-03-02 |
Nippon Shinyaku Co., Ltd. |
ガラクトース誘導体、薬物担体及び医薬組成物
|
WO2006024880A2
(en)
|
2004-08-31 |
2006-03-09 |
Sylentis S.A.U. |
Methods and compositions to inhibit p2x7 receptor expression
|
JP2008522585A
(ja)
|
2004-10-12 |
2008-07-03 |
ザ ロックフェラー ユニバーシティー |
マイクロrna
|
EP2302055B1
(en)
|
2004-11-12 |
2014-08-27 |
Asuragen, Inc. |
Methods and compositions involving miRNA and miRNA inhibitor molecules
|
BRPI0519690A2
(pt)
|
2004-12-30 |
2009-03-03 |
Todd M Hauser |
composiÇÕes e mÉtodos para modular a expressço de genes usando oligonucleotÍdeos autoprotegidos
|
DE602007004463D1
(de)
|
2006-03-01 |
2010-03-11 |
Nippon Shinyaku Co Ltd |
Galactosederivat, arzneimittelträger und medizinische zusammensetzung
|
WO2007134014A2
(en)
|
2006-05-05 |
2007-11-22 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for modulating expression of gcgr
|
EP2700638A1
(en)
|
2006-05-31 |
2014-02-26 |
The Regents Of the University of California |
Purine analogs
|
EP1890152A1
(en)
|
2006-08-14 |
2008-02-20 |
Charite Universitätsmedizin-Berlin |
Determination of renin/prorenin receptor activity
|
JP2008220366A
(ja)
|
2007-02-16 |
2008-09-25 |
National Institute Of Advanced Industrial & Technology |
修飾型pna/rna複合体
|
JP5145557B2
(ja)
|
2007-03-01 |
2013-02-20 |
財団法人ヒューマンサイエンス振興財団 |
マイクロrnaを有効成分として含有する腫瘍増殖抑制剤、および癌治療用医薬組成物
|
CA2681323A1
(en)
|
2007-03-21 |
2008-09-25 |
Brookhaven Science Associates, Llc |
Combined hairpin-antisense compositions and methods for modulating expression
|
CN101121934B
(zh)
|
2007-04-11 |
2011-12-07 |
哈尔滨医科大学 |
多靶点miRNA反义核苷酸的制备方法
|
WO2008137862A2
(en)
|
2007-05-03 |
2008-11-13 |
Rosetta Inpharmatics Llc |
Methods of using mir34 as a biomarker for tp53 functional status
|
JP5296328B2
(ja)
|
2007-05-09 |
2013-09-25 |
独立行政法人理化学研究所 |
1本鎖環状rnaおよびその製造方法
|
US20090123501A1
(en)
|
2007-05-17 |
2009-05-14 |
Baylor College Of Medicine |
Inhibition of the sh2-domain containing protein tyr-phosphatase, shp-1, to enhance vaccines
|
JP5637533B2
(ja)
|
2007-05-23 |
2014-12-10 |
ジーイー ヘルスケア ダーマコン,インク. |
マイクロ−rnaスキャホールドおよび非天然存在型マイクロ−rna
|
DK2164967T3
(en)
|
2007-05-31 |
2015-10-19 |
Univ Iowa Res Found |
Reduction of off-target rna interferenstoksicitet
|
WO2009000520A1
(en)
|
2007-06-25 |
2008-12-31 |
Universität Duisburg-Essen |
Screening-method for polymorphic markers in htra1 gene in neurodegenerative disorders
|
CN101842381A
(zh)
*
|
2007-08-27 |
2010-09-22 |
波士顿生物医药公司 |
作为微小rna模拟物或抑制剂的不对称rna双链体的组合物
|
US8283331B2
(en)
*
|
2007-10-09 |
2012-10-09 |
Children's Medical Center Corporation |
Methods to regulate miRNA processing by targeting Lin-28
|
EP2944694B1
(en)
|
2007-10-12 |
2018-07-11 |
The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of Holy and Undiv. Trinity of Queen Elizabeth near Dublin |
Method for opening tight junctions
|
TW200927177A
(en)
|
2007-10-24 |
2009-07-01 |
Nat Inst Of Advanced Ind Scien |
Lipid-modified double-stranded RNA having potent RNA interference effect
|
TW200930405A
(en)
|
2007-11-15 |
2009-07-16 |
Alcon Res Ltd |
Low density lipoprotein receptor-mediated siRNA delivery
|
EP2233573B1
(en)
|
2007-11-29 |
2013-10-23 |
Suzhou Ribo Life Science Co., Ltd |
A complex molecule interfering the expression of target genes and its preparing methods
|
WO2009082607A2
(en)
|
2007-12-04 |
2009-07-02 |
Alnylam Pharmaceuticals, Inc. |
Targeting lipids
|
US20110159586A1
(en)
|
2007-12-07 |
2011-06-30 |
Halo-Bio Rnai Therapeutics, Inc. |
Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides
|
US20110055965A1
(en)
|
2008-02-15 |
2011-03-03 |
Hiroshi Abe |
Cycle single-stranded nucleic acid complex and method for producing the same
|
KR20100131509A
(ko)
|
2008-03-31 |
2010-12-15 |
내셔날 인스티튜트 오브 어드밴스드 인더스트리얼 사이언스 앤드 테크놀로지 |
Rna 간섭 효과가 높은 2본쇄 지질 수식 rna
|
US20110172295A1
(en)
|
2008-04-11 |
2011-07-14 |
The University Of North Carolina At Chapel Hill |
METHODS AND COMPOSITIONS FOR THE REGULATION OF microRNA PROCESSING
|
WO2009143619A1
(en)
|
2008-05-27 |
2009-12-03 |
Chum |
Methods of treating or preventing obesity and obesity-related hypertension
|
US20100179213A1
(en)
|
2008-11-11 |
2010-07-15 |
Mirna Therapeutics, Inc. |
Methods and Compositions Involving miRNAs In Cancer Stem Cells
|
WO2010058824A1
(ja)
*
|
2008-11-19 |
2010-05-27 |
国立大学法人岐阜大学 |
間葉系細胞の分化を調節するための薬剤及びその利用
|
US8426581B2
(en)
|
2009-03-27 |
2013-04-23 |
Merck Sharp & Dohme Corp. |
RNA interference mediated inhibition of the FCεR1α gene
|
ES2804764T3
(es)
|
2009-06-01 |
2021-02-09 |
Halo Bio Rnai Therapeutics Inc |
Polinucleótidos para la interferencia de ARN multivalente, composiciones y métodos de uso de los mismos
|
EP2454371B1
(en)
|
2009-07-13 |
2021-01-20 |
Somagenics, Inc. |
Chemical modification of small hairpin rnas for inhibition of gene expression
|
US20120258104A1
(en)
|
2009-07-22 |
2012-10-11 |
Cenix Bioscience Gmbh |
Delivery System and Conjugates For Compound Delivery Via Naturally Occurring Intracellular Transport Routes
|
US9096850B2
(en)
|
2009-08-24 |
2015-08-04 |
Sirna Therapeutics, Inc. |
Segmented micro RNA mimetics
|
US20110052666A1
(en)
|
2009-09-03 |
2011-03-03 |
Medtronic, Inc. |
Compositions, Methods, and Systems for SIRNA Delivery
|
EP2496268A4
(en)
|
2009-11-06 |
2013-06-19 |
Univ Chung Ang Ind |
GENE DELIVERY SYSTEMS BASED ON NANOPARTICLES
|
AU2010330814B2
(en)
|
2009-12-18 |
2017-01-12 |
Acuitas Therapeutics Inc. |
Methods and compositions for delivery of nucleic acids
|
SG181904A1
(en)
|
2009-12-23 |
2012-07-30 |
Novartis Ag |
Lipids, lipid compositions, and methods of using them
|
JP2013515697A
(ja)
|
2009-12-23 |
2013-05-09 |
マックスプランク−ゲセルシャフト・ツール・フェーデルング・デル・ヴィッセンシャフテン・エー・ファウ |
インフルエンザ標的
|
EP3560503B1
(en)
|
2010-03-24 |
2021-11-17 |
Phio Pharmaceuticals Corp. |
Rna interference in dermal and fibrotic indications
|
CN101845071B
(zh)
|
2010-03-25 |
2012-02-01 |
北京欧凯纳斯科技有限公司 |
一种2’或3’偶联氨基酸的核苷衍生物、其制备方法及应用
|
JP5555940B2
(ja)
|
2010-04-14 |
2014-07-23 |
国立大学法人佐賀大学 |
増殖糖尿病網膜症の検出方法および予防・治療剤のスクリーニング方法
|
JP5892608B2
(ja)
|
2010-04-19 |
2016-03-23 |
国立研究開発法人理化学研究所 |
機能性核酸の安定化法
|
SI2561078T1
(sl)
|
2010-04-23 |
2019-01-31 |
Cold Spring Harbor Laboratory |
Nove strukturno oblikovane shRNA
|
HUE037500T2
(hu)
|
2010-07-08 |
2018-08-28 |
Bonac Corp |
Egyszálú nukleinsav molekula a génexpresszió szabályozására
|
US8785121B2
(en)
|
2010-07-08 |
2014-07-22 |
Bonac Corporation |
Single-stranded nucleic acid molecule for controlling gene expression
|
WO2012012676A2
(en)
|
2010-07-22 |
2012-01-26 |
The University Of North Carolina At Chapel Hill |
Use of mir-29 for cell protection
|
US8691782B2
(en)
|
2010-08-03 |
2014-04-08 |
Bonac Corporation |
Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
|
KR101894701B1
(ko)
*
|
2010-08-03 |
2018-09-04 |
가부시키가이샤 보낙 |
함질소 지환식 골격을 갖는 일본쇄 핵산 분자
|
EP3406730B1
(en)
|
2010-08-31 |
2022-02-23 |
Sirna Therapeutics, Inc. |
Novel single chemical entities and methods for delivery of oligonucleotides
|
CA2819944A1
(en)
*
|
2010-12-02 |
2012-06-07 |
Daiichi Sankyo Company, Limited |
Modified single-stranded polynucleotide
|
CN102559666B
(zh)
|
2010-12-18 |
2013-12-25 |
中国科学院上海生命科学研究院 |
抑制植物病毒的人工miRNA及其构建和用途
|
JP2014506791A
(ja)
|
2011-02-03 |
2014-03-20 |
マーナ セラピューティクス インコーポレイテッド |
miR−34の合成模倣体
|
CN102784398B
(zh)
|
2011-05-16 |
2014-06-18 |
南京大学 |
内皮抑素作为递送系统和化学合成的rna干扰分子组成的组合物及应用
|
JP6011945B2
(ja)
|
2011-05-20 |
2016-10-25 |
公一 中城 |
マイクロrna又はその発現系を含む組成物
|
EP2527440A1
(en)
|
2011-05-27 |
2012-11-28 |
Institut Curie |
Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
|
JP2013055913A
(ja)
|
2011-09-09 |
2013-03-28 |
Bonac Corp |
遺伝子発現制御のための一本鎖rna分子
|
WO2013077446A1
(ja)
*
|
2011-11-26 |
2013-05-30 |
株式会社ボナック |
遺伝子発現制御のための一本鎖核酸分子
|
US9528111B2
(en)
|
2012-01-07 |
2016-12-27 |
Bonac Corporation |
Single-stranded nucleic acid molecule having amino acid backbone
|
JP2013153736A
(ja)
*
|
2012-01-07 |
2013-08-15 |
Bonac Corp |
ペプチド骨格を有する一本鎖核酸分子
|
EP2824184B1
(en)
*
|
2012-03-04 |
2017-09-27 |
Bonac Corporation |
micro-RNA INHIBITOR
|
AR090905A1
(es)
|
2012-05-02 |
2014-12-17 |
Merck Sharp & Dohme |
Conjugados que contienen tetragalnac y peptidos y procedimientos para la administracion de oligonucleotidos, composicion farmaceutica
|
WO2013180038A1
(ja)
|
2012-05-26 |
2013-12-05 |
株式会社ボナック |
デリバリー機能を有する遺伝子発現制御用の一本鎖核酸分子
|
US9856218B2
(en)
*
|
2013-03-15 |
2018-01-02 |
Ohio State Innovation Foundation |
Inhibitors of PRMT5 and methods of their use
|
SG11201510565TA
(en)
|
2013-05-22 |
2016-01-28 |
Alnylam Pharmaceuticals Inc |
Tmprss6 irna compositions and methods of use thereof
|
WO2015093495A1
(ja)
|
2013-12-16 |
2015-06-25 |
株式会社ボナック |
TGF-β1遺伝子発現制御のための一本鎖核酸分子
|
CN105899663B
(zh)
|
2013-12-26 |
2019-07-26 |
学校法人东京医科大学 |
用于基因表达控制的人工模拟miRNA及其用途
|
CN106068324B
(zh)
|
2013-12-27 |
2020-12-29 |
株式会社博纳克 |
控制基因表达的人工匹配型miRNA及其用途
|
JP6492014B2
(ja)
|
2013-12-27 |
2019-03-27 |
株式会社ボナック |
遺伝子発現制御のための人工マッチ型miRNAおよびその用途
|
WO2015161255A1
(en)
*
|
2014-04-18 |
2015-10-22 |
Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada, Reno |
Methods for enhancing or decreasing the levels of mir124 and mir29 in subjects with muscular dystrophy
|
JP6602847B2
(ja)
|
2015-03-27 |
2019-11-06 |
株式会社ボナック |
デリバリー機能と遺伝子発現制御能を有する一本鎖核酸分子
|
WO2017115872A1
(ja)
|
2015-12-29 |
2017-07-06 |
国立大学法人北海道大学 |
プロレニン遺伝子またはプロレニン受容体遺伝子の発現を抑制する一本鎖核酸分子およびその用途
|